BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
282 hedge funds and large institutions have $6.25B invested in Blueprint Medicines in 2024 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 102 increasing their positions, 88 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $6.02B → $6.25B (+$229M)
0.26% more ownership
Funds ownership: 107.32% → 107.58% (+0.26%)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
282
Holding in Top 10
3
Calls
$134M
Puts
$99.9M
Top Buyers
| 1 | +$78M | |
| 2 | +$77.9M | |
| 3 | +$67.9M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$37.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$22.7M |
Top Sellers
| 1 | -$121M | |
| 2 | -$56.5M | |
| 3 | -$36.3M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$24.4M |
| 5 |
State Street
Boston,
Massachusetts
|
-$22M |